Cencora, Inc. (COR)
Here's Why Cencora (COR) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cencora Q3 Earnings Call Highlights
Cencora NYSE: COR reported fiscal 2026 third-quarter results marked by double-digit adjusted operating income growth, specialty-business momentum and $1 billion in share repurchases, prompting the pharmaceutical services company to raise its full-year adjusted earnings outlook.
Cencora, Inc. (COR) Q3 2026 Earnings Call Transcript
Cencora, Inc. (COR) Q3 2026 Earnings Call Transcript
COR Stock Gains as Q3 Earnings Beat on Segment Growth, EPS View Raised
Cencora's fiscal Q3 EPS beats estimates as broad segment growth lifts profit, prompting a higher 2026 outlook despite a slight revenue miss.
Cencora (COR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Cencora (COR) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Cencora (COR) Surpasses Q3 Earnings Estimates
Cencora (COR) came out with quarterly earnings of $4.48 per share, beating the Zacks Consensus Estimate of $4.37 per share. This compares to earnings of $4 per share a year ago.
What's in Store for These 4 Healthcare Companies This Earnings Season?
McKesson, Cencora, Solventum and PacBio head into earnings with resilient demand offset by tariffs, funding pressure and pricing challenges.
Cencora to Report Q3 Earnings: Is a Beat Likely for the Stock?
COR's Q3 results could reflect specialty pharma strength, oncology expansion and margin gains, even as pricing dynamics and GLP-1 trends pressure revenues.
Countdown to Cencora (COR) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Beyond analysts' top-and-bottom-line estimates for Cencora (COR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2026.
Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Cencora (COR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Add Cencora Stock to Your Portfolio Now
COR's specialty expansion, supply-chain investments and international momentum support growth, though pricing, debt and regulation pose risks.
Bet on 5 Top-Ranked Stocks With Rising P/E
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.
